Election of Representative Director and Chief Executive Officer
2024-08-02
Notice of Relocation of Headquarters
2024-07-01
We have received an investment from SMBC Venture Capital.
2024-06-24
Announcement: Appointment of Chief Financial Officer and Representative Director
2024-06-17
The press release from Kyoto University Hospital regarding the start of the Phase II part of an investigator-initiated clinical trial for a new analgesic drug was published.
2024-04-30
We have received an investment from Innovation Kyoto 2021 Investment Limited Partnership with Kyoto University Innovation Capital Corporation (Kyoto iCAP) as a partner with unlimited liability.
2023-10-27
At the general meeting of shareholders held on October 17, 2023, a resolution was passed to elect the following director. Takashi Kiyoizumi, Director (U.S. Development) (New Appointment)
Our part-time director, Prof. Masatoshi Hagiwara, Department of Anatomy and Developmental Biology, Kyoto University, has received the Special Award from the Japanese Society of Toxicology.(Japanese only)
2023-10-05
We have been selected by the Japan Agency for Medical Research and Development (AMED) for the FY2023 "Drug Discovery Venture Ecosystem Enhancement Project (Drug Discovery Venture Open Call)" (2nd round). Under this project, we will begin full-scale development of our product in the United States.
2023-07-28
